RT
RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.
RTALB | IS
Overview
Corporate Details
- ISIN(s):
- TRERTAL00018
- LEI:
- Country:
- Türkiye
- Address:
- N/A
- Website:
- https://rtalab.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
No description available.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-04 17:10 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu 2. Toplantısı Çağrısı Hk.
|
Turkish | 253.1 KB | |
| 2025-06-04 17:10 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu 2. Toplantısı Çağrısı Hk.
|
Turkish | 290.9 KB | |
| 2025-06-04 17:10 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu 2. Toplantısı Çağrısı Hk.
|
Turkish | 15.8 KB | |
| 2025-06-04 10:58 |
AGM Report
Olağan Genel Kurul Toplantısının Toplantı Nisabı Sağlanamaması Nedeniyle Ertele…
|
Turkish | 417.1 KB | |
| 2025-06-04 10:58 |
AGM Report
Olağan Genel Kurul Toplantısının Toplantı Nisabı Sağlanamaması Nedeniyle Ertele…
|
Turkish | 202.8 KB | |
| 2025-06-04 10:58 |
General Meeting Notice
Olağan Genel Kurul Toplantısının Toplantı Nisabı Sağlanamaması Nedeniyle Ertele…
|
Turkish | 13.7 KB | |
| 2025-05-05 17:11 |
Notice of Dividend Amount
Yönetim Kurulu'nun Kar Payı Dağıtılmamasına İlişkin Teklifi
|
English | 22.4 KB | |
| 2025-05-05 17:11 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu Daveti
|
Turkish | 291.9 KB | |
| 2025-05-05 17:11 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu Daveti
|
Turkish | 253.3 KB | |
| 2025-05-05 17:11 |
General Meeting Notice
2024 Yılı Olağan Genel Kurulu Daveti
|
Turkish | 15.7 KB | |
| 2025-04-30 23:03 |
Interim Report
Sorumluluk Beyanı (31.03.2025)
|
Turkish | 21.5 KB | |
| 2025-04-30 23:03 |
Quarterly Report
Faaliyet Raporu (31.03.2025)
|
Turkish | 871.7 KB | |
| 2025-04-30 23:03 |
Proxy Solicitation & Information Statements
Faaliyet Raporu (31.03.2025)
|
Turkish | 11.4 KB | |
| 2025-04-30 23:02 |
Interim Report
Financial Report
|
Turkish | 2.7 MB | |
| 2025-04-30 23:02 |
Regulatory News Service
Financial Report
|
Turkish | 2.5 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biofarm S.A. | Romania | BIO | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI |